Welcome to LookChem.com Sign In|Join Free

CAS

  • or

508-02-1

Post Buying Request

508-02-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

508-02-1 Usage

Description

Oleanolic acid or oleanic acid is a naturally occurring pentacyclic triterpenoid with the formula of C30H48O3. It was found in the non-glyceride fraction of olive pomace oil and is widely distributed in food and plants where it exists as a free acid or as an aglycone precursor for triterpenoid saponins, in which it can be linked to one or more sugar chains. It is biosynthesized from lupane. It can rearrange to the isomer, ursolic acid, or be oxidized to taraxasterol and amyrin. Oleanolic acid and its derivatives possess several promising pharmacological activities, such as hepatoprotective effects, and anti-inflammatory, antioxidant, or anticancer activities.

Chemical Properties

White needle-like crystals (ethanol), odorless, tasteless. Unstable to acid and alkali. Insoluble in water, soluble in methanol, ethanol, ethyl ether, acetone and chloroform.

Occurrence

The ingredient is mainly extracted from the leaves of Olea europaea and Viscum album L. Besides, it is found in the fruit of ligustrum lucidum ait, the whole grass of swertia mileensis t.n.he et w.l.shi, s. mussotii franch, the leaves and roots of astrantia major, the root bark and stem bark of aralia chinensis, the roots of hemsleya macrosperma c.y.wu , the roots of hemsleya amabilis diels, and the roots of hemsleya chinensis cogn. There is a long history in the herb and fruit which contain oleanolic acid. They play an important role in the treatment of various diseases. Oleanolic acid may be the most effective component in various Chinese medicines.

History

The chemical formula was first identified in 1918. In 1960, Khastgir purified the compound for the first time. Corey identified the structure of oleanolic acid in 1993.Now the compound has been made into a drug and is being marketed in China. As early as 2002, the tablet form of oleanolic acid was listed. In 2010, capsule preparations came into the market, and to date, there is no other listed preparation. Sanofi treated it as antiulcer and NSAIDs candidate in abroad.Although it has anti-inflammatory and anti-ulcer effects, Sanofi stopped the study of developing oleanolic acid into a drug in 1989.

Uses

Oleanolic acid is a triterpenoid known for its anti-inflammatory properties, is commonly present in several medicinal plants. It can Inhibits secretory phospholipase A2 that is mainly used for the treatment of acute jaundiced hepatitis with remarkable efficacy, and also has good effect on chronic hepatitis.?

Indications

Oleanolic acid is included in the Pharmacopoeia of the People's Republic of China (Part 2, volume 3), the British Pharmacopoeia (2017), and the European Pharmacopoeia (8.7th ed.). It is mainly used for the adjuvant treatment of acute infectious icteric hepatitis and acute and chronic hepatitis. It also can be utilized in psoriasis, rheumatoid arthritis, nephritic edema, ascites, stomach with turbid, metrorrhagia, bruises, carbuncle, soreness and weakness of the waist and knees, fetal irritability and so on.

Definition

ChEBI: Oleanolic acid is a pentacyclic triterpenoid that is olean-12-en-28-oic acid substituted by a beta-hydroxy group at position 3. It has a role as a plant metabolite. It is a pentacyclic triterpenoid and a hydroxy monocarboxylic acid. It is a conjugate acid of an oleanolate. It derives from a hydride of an oleanane.

General Description

Oleanolic acid is a hydroxyl pentacyclic triterpenoic acid (HPTA), which exhibits antibacterial, antitumor and antileishmanial activity. It is biosynthesized from lupane. It can rearrange to the isomer, ursolic acid, or be oxidized to taraxasterol and amyrin.

Biochem/physiol Actions

Triterpenoid isolated from medicinal plants. Antitumor and hepatoprotective agent. Oleanolic acid has therapeutic potential for neurodegenerative diseases.

Pharmacology

Liver protection: Pretreatment of 100?mg/kg once a day for 3?days can protect the liver and decrease the activity of enzymes. It achieves by increasing the amount of metallothioneins and liver glucoside transferases to prevent glutathione emptying, to inhibit several subtypes of P450 oxidase, and to prevent combination with toxic substances.Antimicrobial and antiviral effect: Oleanolic acid may inhibit the proliferation or production of NO induced by interferon or in the macrophages by competitively binding to the enzymes necessary for the growth and reproduction of microorganisms or virus and play an anti-inflammatory and antiviral role. EC50 of HIV-1- infected H9 cells is 3.4?mol/L.Effects on metabolism of glucose and lipid: The treatment of 50–100?mg/kg for 4?days achieves the glucosidase activity inhibition, reduction of glucose absorption, inhibition of glycogen phosphorylase, activation of glycogen synthesis, inhibition of protein tyrosine phosphatase 1B, regulation of insulin signaling pathway, and increase of insulin sensitivity, and it may also be achieved by inhibiting the transport of glucose from the stomach to the intestine and transport activity of intestinal villi. 200?mg/kg suspension administrated by gavage for 4?weeks decreases the level of triglycerides, cholesterol, and β-lipoprotein in high-fat animal, and it contributes to increased platelet swimming rate and decreased blood viscosityEffects on immunologic function: 60?mg/kg intraperitoneal injection may regulate the immune system by inhibiting type I allergic reaction, promoting proliferation of lymphocyte and inhibiting enzyme C-3? in the traditional complement pathway.Antioxidant effect: It fights against lipid peroxidation by scavenging free radicals.Other functions: 10–5?mol/L oleanolic acid may inhibit the activity of DNA ligase I active site. It exerts anticancer and anti-mutation effects, and IC50 value is2.2×105 ?mol/L in inhibiting ornithine decarboxylase (ODC) induced by external TPA at the transcriptional level. Oleanolic acid in polyvinylpyrrolidone suspension at the dose of 16?mg/kg by intragastric administration for 30?days also reversibly decreases quality and exercise capacity of mouse sperms.It is reported that it is consistent with the single compartment model, or noncompartmental model, and may be distributed in the compound in accordance with the two compartment models. Eventually, it will be eliminated by P450 oxidase in the liver.

Clinical Use

It is reported that contrast with Western medicine, the 60~90?mg/d oleanolic acid tablets supplemented with vitamin B can treat acute and chronic hepatitis, with effective rates of 94.4% and 69.81%, respectively, in clinical results. It has been listed on the drug manual as adjuvant therapy for acute and chronic hepatitis.

References

1.https://en.wikipedia.org/wirki/Oleanolic_acid2.https://www.ncbi.nlm.nih.gov/mesh/680098283.http://www.sciencedirect.com/science/article/pii/S00319422120000274.http://www.adooq.com/oleanolic-acid-caryophyllin.html

Check Digit Verification of cas no

The CAS Registry Mumber 508-02-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 8 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 508-02:
(5*5)+(4*0)+(3*8)+(2*0)+(1*2)=51
51 % 10 = 1
So 508-02-1 is a valid CAS Registry Number.
InChI:InChI=1/C30H48O3/c1-25(2)14-16-30(24(32)33)17-15-28(6)19(20(30)18-25)8-9-22-27(5)12-11-23(31)26(3,4)21(27)10-13-29(22,28)7/h8,20-23,31H,9-18H2,1-7H3,(H,32,33)/t20?,21?,22?,23-,27-,28+,29+,30-/m0/s1

508-02-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (O0317)  Oleanolic Acid Hydrate  >98.0%(T)

  • 508-02-1

  • 5g

  • 650.00CNY

  • Detail
  • TCI America

  • (O0317)  Oleanolic Acid Hydrate  >98.0%(T)

  • 508-02-1

  • 25g

  • 1,750.00CNY

  • Detail
  • Alfa Aesar

  • (H60445)  Oleanolic acid, 97%   

  • 508-02-1

  • 250mg

  • 1403.0CNY

  • Detail
  • Sigma-Aldrich

  • (42515)  Oleanolicacid  analytical standard

  • 508-02-1

  • 42515-10MG

  • 1,519.83CNY

  • Detail
  • Aldrich

  • (O5504)  Oleanolicacid  ≥97%

  • 508-02-1

  • O5504-100MG

  • 945.36CNY

  • Detail
  • Aldrich

  • (O5504)  Oleanolicacid  ≥97%

  • 508-02-1

  • O5504-500MG

  • 3,510.00CNY

  • Detail
  • Sigma-Aldrich

  • (03920590)  Oleanolicacid  primary pharmaceutical reference standard

  • 508-02-1

  • 03920590-10MG

  • 2,552.94CNY

  • Detail

508-02-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name oleanolic acid

1.2 Other means of identification

Product number -
Other names oleanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:508-02-1 SDS

508-02-1Synthetic route

(4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-(tert-Butyl-dimethyl-silanyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid
152487-68-8

(4aS,6aS,6bR,8aR,10S,12aR,12bR,14bS)-10-(tert-Butyl-dimethyl-silanyloxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 55℃; for 13h;96%
C54H72NO5Pol

C54H72NO5Pol

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane at 20℃; for 0.5h; solid phase reaction;94.6%
C61H76NO6PolS

C61H76NO6PolS

A

3β-[(E)-3-(thiophen-2-yl)acryloxyl]-olean-12-en-28-oic acid
1310058-25-3

3β-[(E)-3-(thiophen-2-yl)acryloxyl]-olean-12-en-28-oic acid

B

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane at 20℃; for 0.5h; solid phase reaction;A 92%
B 0.5 mg
{2-[2-(triphenylmethyl)aminoethoxy]ethoxy}methyl olean-12-en-28-oate
1310058-23-1

{2-[2-(triphenylmethyl)aminoethoxy]ethoxy}methyl olean-12-en-28-oate

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane at 20℃; for 0.5h;89.6%
(4aS,6aS,6bR,10S,12aR)-methyl 10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
25493-69-0, 122798-61-2, 1721-57-9

(4aS,6aS,6bR,10S,12aR)-methyl 10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With Me2AlTeMe In toluene at 50℃; for 10h;80%
oleanolic acid methyl ester
1724-17-0, 73584-64-2

oleanolic acid methyl ester

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With lithium In ethylenediamine for 4h; Heating;70%
With lithium In ethylenediamine for 4h; Heating; other hindered esters;70%
3β-acetyl-12α-bromo-oleanan-28 <*> 13β-olide
86532-12-9

3β-acetyl-12α-bromo-oleanan-28 <*> 13β-olide

A

Oleanolic acid
508-02-1

Oleanolic acid

B

3-dehydroxy-oleanolic acid
17990-43-1

3-dehydroxy-oleanolic acid

Conditions
ConditionsYield
With lithium; ethylenediamine for 2h; Heating;A 35%
B 30%
ursolic acid
77-52-1

ursolic acid

Nocardia sp. NRRL 5646

Nocardia sp. NRRL 5646

A

Oleanolic acid
508-02-1

Oleanolic acid

C

oleanolic acid methyl ester
1724-17-0, 73584-64-2

oleanolic acid methyl ester

Conditions
ConditionsYield
at 28℃; for 120h; pH=7.0; Product distribution; Microbiological reaction;A 21%
B 9%
C 13%
3-hydroxy-23-semicarbazono-olean-12-en-28-oic acid

3-hydroxy-23-semicarbazono-olean-12-en-28-oic acid

sodium ethanolate
141-52-6

sodium ethanolate

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
at 180℃; im Rohr;
3-acetoxy-23-semicarbazono-olean-12-en-28-oic acid

3-acetoxy-23-semicarbazono-olean-12-en-28-oic acid

sodium ethanolate
141-52-6

sodium ethanolate

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
at 160 - 170℃; im Rohr;
sodium acetate
127-09-3

sodium acetate

A

ursolic acid
77-52-1

ursolic acid

B

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With cultured cells of Rabdosia japonica Hara for 96h; Mechanism; labelling studies;
mimonoside A
135754-97-1

mimonoside A

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With hydrogenchloride at 100℃; for 4h;2 mg
mimonoside B
135754-98-2

mimonoside B

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With hydrogenchloride at 100℃; for 4h;
Conditions
ConditionsYield
With sulfuric acid In methanol for 1.5h; Heating;A 348 mg
B 23 mg
C 52 mg
Digitoside B
140208-80-6

Digitoside B

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With sulfuric acid In methanol for 3h; Heating;32 mg
Digitoside A
140208-79-3

Digitoside A

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With sulfuric acid In methanol for 3h; Heating;29 mg
Pseudo-ginsenoside-RI3
143114-86-7

Pseudo-ginsenoside-RI3

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol for 4h; Heating;
Conditions
ConditionsYield
With hydrogenchloride In methanol Heating;
hederacholichiside E
33783-82-3

hederacholichiside E

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With hydrogenchloride at 100℃; for 3h;
momordin I

momordin I

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol for 3h; Heating; Yield given;
Conditions
ConditionsYield
With lithium aluminium tetrahydride; sulfuric acid Multistep reaction;
3-O-[β-D-xylopyranosyl-(1->4)-β-D-glucuronopyranosyl]-28-O-[β-D-glucopyranosyl]oleanolic acid
89827-13-4

3-O-[β-D-xylopyranosyl-(1->4)-β-D-glucuronopyranosyl]-28-O-[β-D-glucopyranosyl]oleanolic acid

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With sulfuric acid at 95℃; for 6h;22 mg
momordin II

momordin II

Oleanolic acid
508-02-1

Oleanolic acid

Conditions
ConditionsYield
With hydrogenchloride In methanol Yield given;
Oleanolic acid
508-02-1

Oleanolic acid

oleanolic acid methyl ester
1724-17-0, 73584-64-2

oleanolic acid methyl ester

Conditions
ConditionsYield
In tetrahydrofuran; diethyl ether at 0℃;100%
In diethyl ether at 0℃; for 24h;98%
With diethyl ether94%
Oleanolic acid
508-02-1

Oleanolic acid

acetic anhydride
108-24-7

acetic anhydride

oleanolic acid 3-acetate
4339-72-4

oleanolic acid 3-acetate

Conditions
ConditionsYield
With pyridine for 10h; Reflux;100%
With pyridine; dmap for 5h;99%
With pyridine; dmap at 20℃;99%
Oleanolic acid
508-02-1

Oleanolic acid

diazomethyl-trimethyl-silane
18107-18-1

diazomethyl-trimethyl-silane

oleanolic acid methyl ester
1724-17-0, 73584-64-2

oleanolic acid methyl ester

Conditions
ConditionsYield
In methanol; benzene100%
In methanol; diethyl ether at 20℃; for 1h;99%
In methanol; diethyl ether; toluene at 20℃; for 0.5h;94%
In methanol; benzene80.1%
In methanol
Oleanolic acid
508-02-1

Oleanolic acid

trityl chloride
76-83-5

trityl chloride

oleanolic acid trityl ester
257614-49-6

oleanolic acid trityl ester

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran tritylationprotection; Heating;100%
With 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran91%
Oleanolic acid
508-02-1

Oleanolic acid

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

C34H46F6O5

C34H46F6O5

Conditions
ConditionsYield
at 20℃; for 0.166667h;100%
Oleanolic acid
508-02-1

Oleanolic acid

methyl iodide
74-88-4

methyl iodide

oleanolic acid methyl ester
1724-17-0, 73584-64-2

oleanolic acid methyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;100%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 24h; Inert atmosphere;100%
With potassium carbonate In N,N-dimethyl-formamide at 0 - 20℃; for 24h; Inert atmosphere;99%
Oleanolic acid
508-02-1

Oleanolic acid

Oleanonsaeure
17990-42-0

Oleanonsaeure

Conditions
ConditionsYield
With Dess-Martin periodane In dichloromethane at 20℃; for 1h; Inert atmosphere;99%
With Jones reagent In dichloromethane; acetone at 0 - 5℃; for 0.75h; Jones Oxidation;99%
With Jones reagent In acetone Cooling with ice;98%
3,3-dimethylglutaric anhydride
4160-82-1

3,3-dimethylglutaric anhydride

Oleanolic acid
508-02-1

Oleanolic acid

3-O-(3',3'-dimethylglutaryl)oleanolic acid

3-O-(3',3'-dimethylglutaryl)oleanolic acid

Conditions
ConditionsYield
With pyridine; dmap for 48h; Heating;99%
With pyridine at 20℃; for 24h;62%
With dmap In pyridine for 36h; Heating;57.1%
With dmap In pyridine Heating;
With pyridine; dmap Heating;
1,4-dioxane-2,6-dione
4480-83-5

1,4-dioxane-2,6-dione

Oleanolic acid
508-02-1

Oleanolic acid

oleanolic acid hemidiglycolate

oleanolic acid hemidiglycolate

Conditions
ConditionsYield
With pyridine; dmap for 12h; Heating;99%
Oleanolic acid
508-02-1

Oleanolic acid

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

(3β)-methylsulfonyloxyolean-12-en-28-oic acid

(3β)-methylsulfonyloxyolean-12-en-28-oic acid

Conditions
ConditionsYield
With pyridine at 80℃; for 1h;99%
With pyridine at 0℃;
Oleanolic acid
508-02-1

Oleanolic acid

3β-Hydroxyolean-28,13-olide
1721-60-4

3β-Hydroxyolean-28,13-olide

Conditions
ConditionsYield
With triethylsilane; N-iodo-succinimide In 2,2,2-trifluoroethanol at 20℃; for 3.5h;98%
With hydrogenchloride; chloroform
Oleanolic acid
508-02-1

Oleanolic acid

dimethyl sulfate
77-78-1

dimethyl sulfate

oleanolic acid methyl ester
1724-17-0, 73584-64-2

oleanolic acid methyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide98%
With sodium hydroxide In ethanol Reflux;96%
With potassium hydroxide
Oleanolic acid
508-02-1

Oleanolic acid

benzyl bromide
100-39-0

benzyl bromide

oleanolic acid benzyl ester
303114-51-4

oleanolic acid benzyl ester

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran at 20℃;98%
With potassium carbonate In tetrahydrofuran; water at 20℃;98%
With tetra-(n-butyl)ammonium iodide; potassium carbonate In tetrahydrofuran; water at 20℃;98%
Oleanolic acid
508-02-1

Oleanolic acid

allyl bromide
106-95-6

allyl bromide

3-hydroxy-olean-12-en-28-oic acid allyl ester
247017-37-4

3-hydroxy-olean-12-en-28-oic acid allyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; acetone at 80℃;98%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere;97%
Stage #1: Oleanolic acid With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 4h;
Stage #2: allyl bromide In N,N-dimethyl-formamide for 8h;
92%
Oleanolic acid
508-02-1

Oleanolic acid

propargyl bromide
106-96-7

propargyl bromide

prop-2-yn-1-yl (4aS,6aS,6bR,12aR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)carboxylate
1161826-31-8

prop-2-yn-1-yl (4aS,6aS,6bR,12aR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)carboxylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 48h;98%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h;97%
With caesium carbonate In tetrahydrofuran; N,N-dimethyl-formamide at 20℃;97%
Oleanolic acid
508-02-1

Oleanolic acid

prenyl bromide
870-63-3

prenyl bromide

3β-hydroxy-olean-12-en-28-prenylate
1383539-87-4

3β-hydroxy-olean-12-en-28-prenylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; acetone at 80℃;98%
Oleanolic acid
508-02-1

Oleanolic acid

ethyl iodide
75-03-6

ethyl iodide

(3β)-ethyl 3-hydroxyolean-12-en-28-oate
110700-49-7

(3β)-ethyl 3-hydroxyolean-12-en-28-oate

Conditions
ConditionsYield
Stage #1: Oleanolic acid With potassium carbonate In N,N-dimethyl-formamide for 0.5h;
Stage #2: ethyl iodide In N,N-dimethyl-formamide at 20℃; for 12h;
97%
With potassium carbonate In N,N-dimethyl-formamide at 45℃;92%
With potassium carbonate In N,N-dimethyl-formamide at 45℃; Large scale;92%
With potassium hydroxide
1 ,6-dibromohexane
629-03-8

1 ,6-dibromohexane

Oleanolic acid
508-02-1

Oleanolic acid

3β-hydroxyoleanane-12-en-28-oic acid(6-bromohexyl) ester
1161826-45-4

3β-hydroxyoleanane-12-en-28-oic acid(6-bromohexyl) ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 12h;97%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 12h;95%
With potassium carbonate In N,N-dimethyl-formamide at 40℃; for 12h;58%
Oleanolic acid
508-02-1

Oleanolic acid

ethyl halide

ethyl halide

ethyl 3β-hydroxyolean-12-en-28-oate

ethyl 3β-hydroxyolean-12-en-28-oate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;97%
Oleanolic acid
508-02-1

Oleanolic acid

C93H186BrNO45

C93H186BrNO45

C123H233NO48

C123H233NO48

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;97%
Oleanolic acid
508-02-1

Oleanolic acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

3β-hydroxyolean-12-ene-28-oic acid tert-butyl dimethylsilyl ester

3β-hydroxyolean-12-ene-28-oic acid tert-butyl dimethylsilyl ester

Conditions
ConditionsYield
Stage #1: Oleanolic acid With triethylamine In dichloromethane at 20℃; for 0.25h;
Stage #2: tert-butyldimethylsilyl chloride In dichloromethane at 20℃;
97%
N-BOC-1,2-diaminoethane
57260-73-8

N-BOC-1,2-diaminoethane

Oleanolic acid
508-02-1

Oleanolic acid

C37H62N2O4

C37H62N2O4

Conditions
ConditionsYield
Stage #1: Oleanolic acid With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0℃; for 0.166667h; Inert atmosphere;
Stage #2: N-BOC-1,2-diaminoethane In N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere;
97%
Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0℃; Reflux;96%
With lithium aluminium tetrahydride In tetrahydrofuran for 3.5h; Heating;95%
With lithium aluminium tetrahydride In tetrahydrofuran at -12 - 20℃; for 24h; Inert atmosphere;94%
Oleanolic acid
508-02-1

Oleanolic acid

2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide
572-09-8

2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide

olean-12-en-28-oic acid 3-hydroxy-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl ester

olean-12-en-28-oic acid 3-hydroxy-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl ester

Conditions
ConditionsYield
With Aliquat 336; potassium carbonate In dichloromethane; water for 48h; Ambient temperature;96%
With potassium carbonate In N,N-dimethyl-formamide at 20℃;92%
With tetrabutylammomium bromide; potassium carbonate In dichloromethane; water for 6h; Heating;78%
Oleanolic acid
508-02-1

Oleanolic acid

benzyl halide

benzyl halide

benzyl 3β-hydroxyolean-12-en-28-oate

benzyl 3β-hydroxyolean-12-en-28-oate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;96%
Oleanolic acid
508-02-1

Oleanolic acid

methyl halide

methyl halide

methyl 3β-hydroxyolean-12-en-28-oate
1724-17-0, 73584-64-2

methyl 3β-hydroxyolean-12-en-28-oate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;96%
Oleanolic acid
508-02-1

Oleanolic acid

12α-chloro-3β-hydroxyoleanan-28,13β-olide

12α-chloro-3β-hydroxyoleanan-28,13β-olide

Conditions
ConditionsYield
With N-chloro-succinimide In 1,2-dimethoxyethane at 20℃; for 96h; Reagent/catalyst; Solvent;96%
Oleanolic acid
508-02-1

Oleanolic acid

benzyl chloride
100-44-7

benzyl chloride

oleanolic acid benzyl ester
303114-51-4

oleanolic acid benzyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃;95%
With potassium carbonate In N,N-dimethyl-formamide at 50℃; for 3h;95%
Stage #1: Oleanolic acid With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 0.5h;
Stage #2: benzyl chloride In N,N-dimethyl-formamide at 120℃; for 0.5h;
95.1%
2,3,4,6-tetra-O-benzoyl-D-glucopyranosyl ortho-(hex-1-ynyl)benzoate
1221151-98-9

2,3,4,6-tetra-O-benzoyl-D-glucopyranosyl ortho-(hex-1-ynyl)benzoate

Oleanolic acid
508-02-1

Oleanolic acid

oleanolic acid 28-O-2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl ester
676530-80-6

oleanolic acid 28-O-2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl ester

Conditions
ConditionsYield
With trifluoromethanesulfonyloxy(triphenylphosphine)gold(I); boron trifluoride diethyl etherate; 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane at 20℃; Molecular sieve; Inert atmosphere; chemoselective reaction;95%

508-02-1Relevant articles and documents

A bidesmosidic oleanolic acid saponin from Panax pseudo-ginseng.

Shukla,Thakur,Pachaly

, p. 1046 - 1048 (1992)

A novel triterpenoid saponin, pseudo-ginsenoside-RI3, isolated from the rhizomes of Panax pseudo-ginseng subsp. himalaicus var. angustifolius has been characterized as 3-O-beta-D-glucopyranosyl(1----2)-beta-D-glucuronopyranosyl (1----6)-beta-D-glucopyranosyl 28-O-beta-D-xylopyranosyl-olean-12-en-28-oic acid ester by physicochemical methods.

Triterpenes from Cigarrilla mexicana

Mata, Rachel,Rios, Lizeth,del Rayo Camacho, Ma,Reguero, Ma Teresa,Lorence, David

, p. 1887 - 1889 (1988)

-From the aerial parts of Cigarrilla mexicana 3β, 23-dihydroxy-urs-12-en-28-oic acid, a new natural product, has been isolated together with the.

Oleanolic acid from antifilarial triterpene saponins of Dipterocarpus zeylanicus induces oxidative stress and apoptosis in filarial parasite Setaria digitata in?vitro

Senathilake,Karunanayake,Samarakoon,Tennekoon,de Silva,Adhikari

, p. 13 - 21 (2017)

Absence of a drug that kills adult filarial parasites remains the major challenge in eliminating human lymphatic filariasis (LF); the second leading cause of long-term and permanent disability. Thus, the discovery of novel antifilarial natural products with potent adulticidal activity is an urgent need. In the present study, methanol extracts of leaves, bark and winged seeds of Dipterocarpus zeylanicus (Dipterocarpaceae) were investigated for macro and microfilaricidal activity. Two antifilarial triterpene saponins were isolated from winged seed extracts by bioactivity guided chromatographic separation and identified using Nuclear Magnetic Resonance and mass spectroscopic analysis as oleanolic acid 3-O-β-D- glucopyranoside (1) (IC50?= 20.54 μM for adult worms, 19.71 μM for microfilariae ) and oleanolic acid 3-O-α-L-arabinopyranoside (2) (IC50?= 29.02 μM for adult worms, 25.99 μM for microfilariae). Acid hydrolysis of both compounds yielded oleanolic acid (3) which was non or least toxic to human peripheral blood mono nuclear cells (Selectivity index?= >10) while retaining similar macrofilaricidal (IC50?= 38.4 μM) and microfilaricidal (IC50?= 35.6 μM) activities. In adult female worms treated with 50 and 100 μM doses of oleanolic acid, condensation of nuclear DNA, apoptotic body formation and tissue damage was observed by using Hoechst 33342 staining, TUNEL assay and Hematoxylin and Eosin staining respectively. A dose dependent increase in caspase 3/CED3 activity and decrease in total protein content were also observed in these parasites. A dose dependant DNA fragmentation was observed in adult parasites and microfilariae. Decreased levels of reduced glutathione (GSH) and elevated levels of glutathione S transferase (GST), superoxide dismutase (SOD) and reactive oxygen species (ROS) were also observed in parasites treated with oleanolic acid indicating an oxidative stress mediated apoptotic event. Compound 3/oleanolic acid was thus identified as a potent and safe antifilarial compound in?vitro.

-

Forgacs,P.,Provost,J.

, p. 1689 (1981)

-

Antileishmanial activity of natural diterpenes from Cistus sp. and semisynthetic derivatives thereof

Fokialakis, Nikolas,Kalpoutzakis, Eleftherios,Tekwani, Babu Lal,Skaltsounis, Alexios Leandros,Duke, Stephen Oscar

, p. 1775 - 1778 (2006)

Eleven cis-clerodane diterpenes, seven labdane type diterpenes and one triterpene isolated from Cistus monspeliensis and the resin "Ladano" of Cistus creticus subsp. creticus were evaluated against Leishmania donovani promastigotes, the causative agent for visceral leishmaniasis. In addition, eleven semisynthetic manoyl oxide, seventeen labdane type derivatives and a triterpene were also evaluated for their antileishmanial activity. 18-Acetoxy-cis-clerod-3-en-15-ol, 15,18-diacetoxy-cis-clerod-3-ene and 13-(E)-8a-hydroxylabd-13-en-15-ol 2-chloroethylcarbamate exhibited the most potent and selective leishmanicidal activity with IC50 values of 3.3 μg/ml, 3.4 μg/ml and 3.5 μg/ml, respectively.

Biosynthesis of Triterpenes, Ursolic Acid and Oleanolic Acid, from Acetate in Tissue Cultures of Rabdosia japonica Hara

Seo, Shujiro,Uomori, Atsuko,Yoshimura, Yohko,Takeda, Ken'ichi,Sankawa, Ushio,et al.

, p. 1141 - 1143 (1986)

1,2-Hydride shifts in the biosynthesis of ursolic acid (2) and oleanolic acid (6), 20-H from C-19, 19-H from C-18, and 18-H from C-13 in (2) and 19-H from C-18 and 18-H from C-13 in (6), were verified in cultured cells of Rabdosia japonica Hara fed with acetate.

-

Taggart,Richter

, p. 351 (1937)

-

Araliasaponins I-XI, triterpene saponins from the roots of Aralia decaisneana

Miyase, Toshio,Shiokawa, Ken-Ichi,Zhang, Dong Ming,Ueno, Akira

, p. 1411 - 1418 (1996)

Seven new oleanane-type and four new ursane-type triterpene saponins, named araliasaponins I-XI were isolated from the roots of Aralia decaisneana, together with four known triterpene saponins. On the basis of the chemical and spectroscopic evidence, the structures of these new saponins were elucidated as follows: 3-O-β-D-xylopyranosyl-(1 → 3)-β-D-glucopyranosyl-(1 → 3)-[β-D-xylopyranosyl-(1 → 2)]-α-L-arabinopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-α-L-arabinopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl-(1 → 6)-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-[β-D-xylopyranosyl-(1 → 2)]-α-L-arabinopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl-(1 → 6)-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-[β-D-xylopyranosyl-(1 → 2)-β-D-glucopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-[β-D-xylopyranosyl-(1 → 2)]-β-D-galactopyranosyl oleanolic acid, 3-O-β-D-glucopyranosyl(1 → 3)-[β-D-xylopyranosyl-(1 → 2)]-β-D-galactopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-[β-D-xylopyranosyl-(1 → 2)]-β-D-galactopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl(1 → 6)-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-β-D-xylopyranosyl-(1 → 2)-α-L-arabinopyranosyl ursolic acid 28-O-β-D-glucopyranosyl ester, 3-O-β-D-glucopyranosyl-(1 → 3)-[β-D-xylopyranosyl-(1 → 2)]-α-L-arabinopyranosyl ursolic acid, 3-O-β-D-glucopyranosyl-(1 → 3)-α-L-arabinopyranosyl ursolic acid 28- O-β-D-glucopyranosyl-(1 → 6)-β-D-glucopyranosyl ester and 3-O-β-D-glucopyranosyl-(1 → 3)-(β-D-xylopyranosyl-(1 → 2)]-β-D-glucopyranosyl ursolic acid 28-O-β-D-glucopyranosyl ester. Copyright

Triterpenoid saponins from Albizia boromoensis Aubrv. & Pellegr

Not, Olivier Placide,Jihu, Dong,Antheaume, Cyril,Guillaume, Dominique,Pegnyemb, Dieudonn Emmanuel,Kilhoffer, Marie Claude,Lobstein, Annelise

, p. 37 - 42 (2015)

As part of our search of new bioactive saponins from Cameroonian medicinal plants, phytochemical investigation of the roots of Albizia boromoensis led to the isolation of four new oleanane-type saponins, named boromoenosides A-D (1-4). Their structures were established by direct interpretation of their spectral data, mainly HRESIMS, 1D NMR (1H, 13C NMR, and DEPT) and 2D NMR (COSY, NOESY, HSQC and HMBC), and by comparison with the literature data. All isolated saponins were assayed for their cytotoxicity against U-87 MG human glioblastoma cell lines and TG1 glioblastoma stem-like cells with no positive activity detected.

Akimaliev et al.

, (1976)

Achyranthosides A and B, novel cytotoxic saponins from Achyranthes fauriei root

Ida, Yoshiteru,Satoh, Yohko,Katoh, Mariko,Katsumata, Masumi,Nagasao, Miki,Yamaguchi, Kentaro,Kamei, Hideo,Shoji, Junzo

, p. 6887 - 6890 (1994)

Two new saponins, achyranthosides A and B, were isolated from Achyranthes fauriei root, and their structures were elucidated on the basis of chemical and physical evidences. Achyranthoside A methyl ester was found to have significant cytotoxic activity against human colon carcinoma and murine melanoma cells.

Cytotoxic triterpenoid saponins from Thalictrum atriplex

Meng, FanCheng,Wei, XiaoDong,Sun, Yan,Zeng, QingHong,Wang, Guowei,Lan, XiaoZhong,Liao, ZhiHua,Chen, Min

, p. 5757 - 5764 (2020/10/20)

Two new cycloartane glycosides, cycloatriosides A and B (1–2), and a new oleanolic acid glycoside, thaliatrioside A (3), along with 7 known triterpenoids (4–10) were isolated from Thalictrum atriplex. The structures of the new compounds were established as 3-O-β-D-galactopyranosyl (20S, 24 R)-3β,16β,25,29-tetrahydroxy-20,24-epoxycycloartane-29-O-β-D-glucopyranoside (1), 3-O-β-D-glucopyranosyl-(1→2)-α-arabinopyranosyl-3β,22ξ,30-trihydroxycycloart-24-en-21-oic acid α-L-arabinopyranosyl-(1→6)-β-D-glucopyranoside (2) and 3-O-[α-L-rhamnopyranosyl-(1→3)-β-D-xylopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranosyl]-oleanolic acid 28-O-β-D-glucopyranosyl ester (3) on the basis of extensive NMR and HR-ESI-MS analyses, along with acid hydrolysis. Their cytotoxic activities against human lung cancer cells A549 and human breast cancer cells MDA-MB-231 were evaluated using MTT method. Compound 9 showed cytotoxicity against MDA-MB-231 cell line with the IC50 value of 72.53 ± 1.08 μM.

Albidosides H and I, two new triterpene saponins from the barks of Acacia albida Del. (Mimosaceae)

Tchoukoua, Abdou,Kuiate Tabopda, Turibio,Konga Simo, Ingrid,Uesugi, Shota,Ohno, Misa,Kimura, Ken-ichi,Kwon, Eunsang,Momma, Hiroyuki,Shiono, Yoshihito,Ngadjui, Bonaventure Tchaleu

, p. 924 - 932 (2018/02/15)

Two new triterpene saponins, albidosides H (1) and I (2), along with the three known saponins were isolated from the barks of Acacia albida. Their structures were elucidated on the basis of extensive 1D- and 2D-NMR studies and mass spectrometry. Albidosid

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 508-02-1